Stock Options (Details 1) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Nov. 30, 2022 |
Aug. 31, 2022 |
Aug. 31, 2021 |
|
| Stock Options | |||
| Beginning Balance, Outstanding | 206,170 | ||
| Expired/Cancelled | (3,334) | ||
| Granted | 44,600 | 222,000 | |
| Ending Balance, Outstanding | 469,436 | 424,836 | |
| Ending Balance, Exercisable | 441,963 | ||
| Weighted average exercise price, Expired/Cancelled | $ 9.60 | ||
| Weighted average exercise price, Granted | $ 2.04 | 4.21 | |
| Weighted average exercise price, Beginning Balance, Outstanding | 5.35 | $ 6.45 | $ 8.90 |
| Weighted average exercise price, exercisable | $ 5.41 | ||
| Weighted Average Remaining Contractual Term, Outstanding (Years) | 3 years 10 months 28 days | 3 years 8 months 8 days | |
| Weighted Average Remaining Contractual Term, Exercisable (Years) | 3 years 10 months 24 days | ||
| Aggregate intrinsic value, granted | $ 5,175 | ||
| Aggregate Intrinsic Value, Exercisable | 41,200 | ||
| Aggregate Intrinsic Value, Outstanding | $ 46,375 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|